A – Agilent Technologies, Inc.
A — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
1.7
Margin Of Safety %
7
Put/Call OI Ratio
0.74
EPS Next Q Diff
0.14
EPS Last/This Y
1.38
EPS This/Next Y
0.6
Price
114.02
Target Price
162.8
Analyst Recom
1.59
Performance Q
-17.36
Upside
-12.4%
Beta
1.29
Ticker: A
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-02 | A | 118.15 | 0.85 | 0.55 | 24555 |
| 2026-03-04 | A | 120.56 | 0.88 | 1.08 | 25057 |
| 2026-03-05 | A | 118.1 | 0.90 | 4.97 | 25332 |
| 2026-03-09 | A | 116.67 | 0.84 | 1.08 | 26060 |
| 2026-03-10 | A | 115.42 | 0.85 | 1.46 | 26463 |
| 2026-03-11 | A | 115.42 | 0.85 | 2.79 | 26507 |
| 2026-03-12 | A | 111.58 | 0.92 | 17.17 | 27738 |
| 2026-03-17 | A | 112.72 | 0.93 | 1.75 | 27822 |
| 2026-03-18 | A | 111.49 | 0.90 | 1.48 | 27553 |
| 2026-03-19 | A | 111.7 | 0.86 | 15.49 | 26984 |
| 2026-03-20 | A | 111.28 | 0.81 | 0.33 | 26462 |
| 2026-03-23 | A | 112.05 | 0.83 | 0.24 | 17676 |
| 2026-03-24 | A | 114.18 | 0.77 | 0.72 | 18671 |
| 2026-03-25 | A | 112.97 | 0.74 | 1.09 | 19310 |
| 2026-03-26 | A | 113.52 | 0.75 | 0.54 | 19682 |
| 2026-03-27 | A | 110.26 | 0.74 | 0.63 | 19825 |
| 2026-03-30 | A | 112.04 | 0.74 | 0.68 | 19904 |
| 2026-03-31 | A | 113.96 | 0.74 | 0.08 | 19968 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-02 | A | 118.14 | 6.3 | 222.4 | 5.93 |
| 2026-03-03 | A | 119.02 | 7.3 | 281.2 | 5.96 |
| 2026-03-04 | A | 120.57 | 7.3 | 291.0 | 5.96 |
| 2026-03-05 | A | 118.09 | 7.3 | 233.4 | 5.96 |
| 2026-03-06 | A | 115.04 | 7.3 | 223.9 | 5.96 |
| 2026-03-09 | A | 116.66 | 7.5 | 298.7 | 5.97 |
| 2026-03-10 | A | 115.46 | 7.5 | 257.2 | 5.97 |
| 2026-03-11 | A | 115.43 | 7.5 | 275.7 | 5.97 |
| 2026-03-12 | A | 111.62 | 7.5 | 217.8 | 5.97 |
| 2026-03-13 | A | 111.51 | 7.5 | 272.9 | 5.97 |
| 2026-03-17 | A | 112.70 | 7.5 | 288.2 | 5.97 |
| 2026-03-18 | A | 111.45 | 7.5 | 254.8 | 5.97 |
| 2026-03-19 | A | 111.67 | 7.5 | 152.4 | 5.97 |
| 2026-03-20 | A | 111.30 | 7.5 | 143.0 | 5.97 |
| 2026-03-23 | A | 112.03 | 7.5 | 160.5 | 5.97 |
| 2026-03-24 | A | 114.20 | 7.5 | 181.3 | 5.97 |
| 2026-03-25 | A | 112.97 | 7.5 | 132.7 | 5.97 |
| 2026-03-26 | A | 113.51 | 7.5 | 157.5 | 5.97 |
| 2026-03-27 | A | 110.21 | 7.5 | 103.5 | 5.97 |
| 2026-03-30 | A | 112.02 | 7.5 | 176.0 | 5.97 |
| 2026-03-31 | A | 114.02 | 7.5 | 178.9 | 5.97 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-02 | A | -2.68 | -0.13 | 1.52 |
| 2026-03-03 | A | -2.68 | -0.13 | 1.52 |
| 2026-03-04 | A | -2.68 | -0.13 | 1.52 |
| 2026-03-05 | A | -2.43 | -0.13 | 1.52 |
| 2026-03-06 | A | -2.43 | -0.13 | 1.52 |
| 2026-03-09 | A | -2.43 | -0.19 | 1.52 |
| 2026-03-10 | A | -2.43 | -0.19 | 1.52 |
| 2026-03-11 | A | -2.43 | -0.19 | 1.62 |
| 2026-03-12 | A | -2.43 | -0.19 | 1.62 |
| 2026-03-13 | A | -2.43 | -0.19 | 1.62 |
| 2026-03-17 | A | -2.43 | -0.18 | 1.62 |
| 2026-03-18 | A | -2.43 | -0.18 | 1.62 |
| 2026-03-19 | A | -2.43 | -0.18 | 1.62 |
| 2026-03-20 | A | -2.43 | -0.18 | 1.62 |
| 2026-03-23 | A | -2.43 | -0.18 | 1.62 |
| 2026-03-24 | A | -2.43 | -0.18 | 1.62 |
| 2026-03-25 | A | -2.43 | -0.18 | 1.70 |
| 2026-03-26 | A | -2.43 | -0.18 | 1.70 |
| 2026-03-27 | A | -2.43 | -0.18 | 1.70 |
| 2026-03-30 | A | -2.43 | -0.19 | 1.70 |
| 2026-03-31 | A | -2.43 | -0.19 | 1.70 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.36
Avg. EPS Est. Current Quarter
1.41
Avg. EPS Est. Next Quarter
1.5
Insider Transactions
-2.43
Institutional Transactions
-0.19
Beta
1.29
Average Sales Estimate Current Quarter
1798
Average Sales Estimate Next Quarter
1830
Fair Value
122.31
Quality Score
93
Growth Score
82
Sentiment Score
54
Actual DrawDown %
36.5
Max Drawdown 5-Year %
-43.2
Target Price
162.8
P/E
25.13
Forward P/E
17.33
PEG
1.86
P/S
4.56
P/B
4.66
P/Free Cash Flow
32.44
EPS
4.54
Average EPS Est. Cur. Y
5.97
EPS Next Y. (Est.)
6.57
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
18.26
Relative Volume
0.89
Return on Equity vs Sector %
-8.8
Return on Equity vs Industry %
7.6
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
178.9
◆
A
Healthcare
$113.98
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
43.9
Range 1M
37.9%
Sup Dist
2.6%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
6.8%
EPS NY
10.2%
52W%
27.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+24.2% upside
Upside
+24.2%
Quality
93
MoS
7%
Agilent Technologies, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 18000
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
A
Latest News
—
Caricamento notizie per A…
stock quote shares A – Agilent Technologies, Inc. Stock Price stock today
news today A – Agilent Technologies, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch A – Agilent Technologies, Inc. yahoo finance google finance
stock history A – Agilent Technologies, Inc. invest stock market
stock prices A premarket after hours
ticker A fair value insiders trading